Australia markets open in 6 hours 17 minutes

ABBV Jan 2023 115.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
39.760.00 (0.00%)
As of 09:39AM EDT. Market open.
Full screen
Loading interactive chart…
  • Motley Fool

    These 5 Top Stocks Are Set to Outperform in a Recession

    The Federal Reserve is grappling with elevated inflation by taking a hawkish stance and raising interest rates. Sprinkle in solid growth companies whose stock has fallen out of favor, yet for which the secular bull case remains intact.

  • Zacks

    AbbVie (ABBV) Gains But Lags Market: What You Should Know

    AbbVie (ABBV) closed the most recent trading day at $153.93, moving +0.08% from the previous trading session.

  • Motley Fool

    This Blockbuster Drug from AbbVie Is Closer to Another Major Indication

    The European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) recently adopted a positive opinion that recommended the approval of AbbVie's (NYSE: ABBV) Rinvoq for what would be its fifth indication in that market. This would be to treat patients with moderate-to-severe ulcerative colitis who had an inadequate response to conventional therapies or biologic agents. A decision for Rinvoq as a treatment for moderate-to-severe ulcerative colitis patients from the European Commission is expected in the third quarter of this year.